Busch is in search of a "chief tasting officer" as it expands its "Dog Brew," a canine-friendly, alcohol-free bone broth, and is willing to compensate the chosen pup $20,000 for the role.
According to Anheuser-Busch, the role will have very important responsibilities, including leading Dog Brew's flavor portfolio expansion.
The job will also include taste-testing and quality control while serving as a product ambassador.
The chosen pup will also be a featured content creator on Busch's social channels.
Other perks that come with the job include pet insurance and free Busch Dog Brew.
Qualifications for the position include a refined palate and an outstanding sense of smell.
Interested pet parents can post a picture of their dog on social media along with their qualifications and the hashtag #BuschCTOcontest.


American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Washington Post Publisher Will Lewis Steps Down After Layoffs
Instagram Outage Disrupts Thousands of U.S. Users
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 



